DD136745A5 - Verfahren zur herstellung von auranofin - Google Patents

Verfahren zur herstellung von auranofin

Info

Publication number
DD136745A5
DD136745A5 DD78204951A DD20495178A DD136745A5 DD 136745 A5 DD136745 A5 DD 136745A5 DD 78204951 A DD78204951 A DD 78204951A DD 20495178 A DD20495178 A DD 20495178A DD 136745 A5 DD136745 A5 DD 136745A5
Authority
DD
German Democratic Republic
Prior art keywords
auranofin
preparing
preparing auranofin
Prior art date
Application number
DD78204951A
Other languages
German (de)
English (en)
Inventor
Davin T Hill
Blaine M Sutton
Ivan Lantos
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of DD136745A5 publication Critical patent/DD136745A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Glass Compositions (AREA)
  • Cosmetics (AREA)
DD78204951A 1977-04-21 1978-04-21 Verfahren zur herstellung von auranofin DD136745A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,603 US4131732A (en) 1977-04-21 1977-04-21 Method for preparing auranofin

Publications (1)

Publication Number Publication Date
DD136745A5 true DD136745A5 (de) 1979-07-25

Family

ID=25148131

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78204951A DD136745A5 (de) 1977-04-21 1978-04-21 Verfahren zur herstellung von auranofin

Country Status (20)

Country Link
US (1) US4131732A (it)
AR (1) AR215695A1 (it)
AT (1) AT361507B (it)
BG (1) BG28716A3 (it)
CH (1) CH633561A5 (it)
CS (1) CS194843B2 (it)
DD (1) DD136745A5 (it)
DK (1) DK150858C (it)
ES (1) ES468938A1 (it)
FI (1) FI64165C (it)
FR (1) FR2387996A1 (it)
IE (1) IE47046B1 (it)
IL (1) IL54528A0 (it)
IT (1) IT1094084B (it)
NO (1) NO146328C (it)
PL (1) PL111162B1 (it)
PT (1) PT67904B (it)
SE (1) SE444568B (it)
SU (1) SU795486A3 (it)
YU (1) YU39417B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301152A (en) * 1979-10-26 1981-11-17 Merck & Co., Inc. Immunologic adjuvant
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
CN1057092C (zh) * 1997-10-31 2000-10-04 昆明贵金属研究所 金诺芬的制备方法
CA2814694C (en) * 2010-10-12 2019-01-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis
WO2016124936A1 (en) 2015-02-06 2016-08-11 Auspherix Limited Inhibition of microbial persister cells
JP2018504434A (ja) 2015-02-06 2018-02-15 オースフェリクス・リミテッドAuspherix Limited オーラノフィンを使用してバイオフィルムを抑制及び分散する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757672A (fr) * 1969-10-28 1971-04-19 Smith Kline French Lab Complexes d'auro-trialcoylphosphine de 1-beta-D-glucopyranosides
DK135897B (da) * 1969-10-28 1977-07-11 Smith Kline French Lab Fremgangsmåde til fremstilling af trialkylphosphinguldhalogenider.
DK129847B (da) * 1969-10-28 1974-11-25 Smith Kline French Lab Analogifremgangsmåde til fremstilling af trialkylphosphinguldkomplekser af 1-β-D-glucopyranosider.

Also Published As

Publication number Publication date
PL206281A1 (pl) 1979-03-12
DK150858B (da) 1987-07-06
IT7822402A0 (it) 1978-04-17
YU39417B (en) 1984-12-31
NO146328B (no) 1982-06-01
BG28716A3 (en) 1980-06-16
FR2387996A1 (fr) 1978-11-17
PT67904A (en) 1978-05-01
AR215695A1 (es) 1979-10-31
ES468938A1 (es) 1978-12-16
IE47046B1 (en) 1983-12-14
PT67904B (en) 1979-10-15
US4131732A (en) 1978-12-26
ATA274678A (de) 1980-08-15
SE7804208L (sv) 1978-10-22
PL111162B1 (en) 1980-08-30
NO146328C (no) 1982-09-08
DK163978A (da) 1978-10-22
FI64165B (fi) 1983-06-30
SU795486A3 (ru) 1981-01-07
NO781391L (no) 1978-10-24
SE444568B (sv) 1986-04-21
DK150858C (da) 1987-12-07
IE780753L (en) 1978-10-21
FR2387996B1 (it) 1980-08-01
CS194843B2 (en) 1979-12-31
CH633561A5 (de) 1982-12-15
FI781155A (fi) 1978-10-22
FI64165C (fi) 1983-10-10
YU95478A (en) 1982-10-31
IT1094084B (it) 1985-07-26
IL54528A0 (en) 1978-07-31
AT361507B (de) 1981-03-10

Similar Documents

Publication Publication Date Title
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
DD135380A5 (de) Verfahren zur herstellung von 4-acylamino-phenyl-aethanolaminen
DD129103A5 (de) Verfahren zur herstellung von n-phosphonomethylglycin
DD135500A5 (de) Verfahren zur herstellung von polyaetheramid-saeuren
DD136616A5 (de) Verfahren zur herstellung von 1,4:3,6-dianhydro-d-glucit-2-nitrat
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
DD135482A5 (de) Verfahren zur herstellung von p-benzochinon
DD138651A5 (de) Verfahren zur herstellung von alpha-fluormethyl-alpha-amino-alkansaeuren
DD135383A5 (de) Verfahren zur herstellung von 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-onen
DD137098A5 (de) Verfahren zur herstellung von cyclobutanonen
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
DD131015A5 (de) Verfahren zur herstellung von acylcyaniden(b)
DD131556A5 (de) Verfahren zur herstellung von 5-m-tolyoxyuracil
DD134089A5 (de) Verfahren zur herstellung von 4-diphenylmethylen-1-hydroxybenzylpiperidinen
DD136745A5 (de) Verfahren zur herstellung von auranofin
DD137926A5 (de) Verfahren zur herstellung von n-substituierten alpha-ketocarbonsaeureamiden
DD138202A5 (de) Verfahren zur herstellung von veraetherten cycloalkanolen
DD131013A5 (de) Verfahren zur herstellung von alpha-ketocarbonsaeuren(b)
DD132431A5 (de) Verfahren zur herstellung von aryloxy-1-amino-3-propanolen-2
DD134517A5 (de) Verfahren zur herstellung von p-nitroso-diphenylhydroxylaminen
DD134524A5 (de) Verfahren zur herstellung von 1-oxadethiacephamverbindungen
DD135908A5 (de) Verfahren zur herstellung von halogenarylmalonamidooxacephalosporinen
DD131088A5 (de) Verfahren zur herstellung von diaminoalkoxybenzolen
DD135481A5 (de) Verfahren zur herstellung von delta-oxoacetalen
DD131178A1 (de) Verfahren zur herstellung alpha-cyanidsubstituierter styrylfarbstoffe